Acorda Therapeutics makes appointment
This article was originally published in Scrip
Acorda Therapeutics (US) has named Dr Adrian Rabinowicz senior vice-president and head, medical affairs. He will be responsible for the company's medical communications and scientific affairs departments, medical education programmes and a field-based team of regional scientific managers. Dr Rabinowicz joins from Bayer HealthCare Pharmaceuticals, where he most recently served as vice-president and head of US medical affairs – speciality medicine – and led the central nervous system and haematology medical teams.